📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-?B and regulating protein synthesis/degradation. (2022)

First Author: Yi X

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.1056460

PubMed Identifier: 36618945

Publication URI: http://europepmc.org/abstract/MED/36618945

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812